Open AccessFeasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men
Author(s) -
Moupali Das,
Deirdre Santos,
Tim Matheson,
Glenn-Milo Santos,
Priscilla Lee Chu,
Eric Vittinghoff,
Steven Shoptaw,
Grant Colfax
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328336e98b
Subject(s) - medicine , placebo , bupropion , adverse effect , randomized controlled trial , methamphetamine , urine , meth , clinical trial , physical therapy , smoking cessation , chemistry , alternative medicine , monomer , organic chemistry , pathology , acrylate , polymer
To determine whether actively using, methamphetamine (meth)-dependent men who have sex with men (msm) could be enrolled and retained in a pharmacologic intervention trial, and the degree to which participants would adhere to study procedures, including medication adherence. study design: phase ii randomized, double-blind trial of bupropion vs. placebo.